Anumana的封面图片
Anumana

Anumana

医疗设备制造业

Cambridge,MA 21,006 位关注者

Unlocking the Language of the Heart & Transforming Cardiac Through Cutting-Edge AI Solutions

关于我们

Anumana? is harnessing industry-leading AI and translational science to decode electrical signals from the heart as never before, empowering healthcare providers to transform patient care throughout the cardiac clinical pathway. Serious cardiovascular diseases affect millions of people worldwide, often going undiagnosed until symptoms advance and patients deteriorate. Unfortunately, these conditions can remain undiagnosed until the patient suffers a life-threatening event. Innovations enabling earlier diagnoses could address this unmet medical need and empower healthcare providers to intervene with life-saving treatments. Anumana recently acquired NeuTrace and is leveraging the power of novel ECG-EGM-EMR integration for clinically valuable, actionable insights. With nference’s proprietary nSights real-world evidence generation platform, built on data from leading health systems, we combine unparalleled longitudinal structured and unstructured electronic medical record data with diagnostic and interventional ECGs and EGMs. By applying AI techniques to these electrical signals from the heart, the company has uncovered clinically critical electrical signatures and patterns unrecognizable to the human eye. The resulting software products can be integrated into routine clinical practice for earlier disease diagnosis and in-procedure decision-making. Anumana’s 75+ peer-reviewed publications and ongoing research show significant promise to detect and diagnose otherwise hidden conditions earlier and uncover actionable insights for valuable patient interventions. The opportunity to offer clinical decision support tools for each unique patient throughout the cardiac care continuum paves the way for precision medicine. Anumana strives to introduce a new standard of care in cardiac clinical care supported by reimbursement.

网站
https://anumana.ai
所属行业
医疗设备制造业
规模
51-200 人
总部
Cambridge,MA
类型
私人持股
创立
2021

地点

  • 主要

    One Main Street, Suite 400

    East Arcade, 4th Floor

    US,MA,Cambridge,02142

    获取路线

Anumana员工

动态

  • 查看Anumana的组织主页

    21,006 位关注者

    We’re gearing up for #ACP 2025 in New Orleans! ?? Find us at Booth #1331 & the Tech Hub to see how Anumana’s FDA-cleared, AI-enabled ECG technology is transforming early detection of low ejection fraction. Here’s what’s happening at ACP 2025: ? Experience ECG-AI? LEF in action with a product demo & meet our team at our booth or at the ACP Tech Hub ? Join our Tech Hub Presentation on April 3 at 12:50 PM: hear from our Senior Medical Director, Wui Ip to learn about the clinical evidence behind ECG-AI? LEF and how it’s used in practice ?? Schedule a meeting with us through our website –? https://lnkd.in/ePey6-Ha? We’re excited to be back at ACP — see you soon in NOLA! #AIinMedicine #InternalMedicine #PrimaryCare #ECGAI #ACP2025?

    • 该图片无替代文字
  • 查看Anumana的组织主页

    21,006 位关注者

    We’re heading to ACC.25 this month!? The future of cardiac care is evolving, and Anumana is at the forefront. Join us in Chicago as we showcase how ECG-AI? LEF, our FDA-cleared technology, unlocks the potential of a standard 12-lead ECG, empowering earlier detection of low ejection fraction.? ?? Visit us at Booth #9004 to experience:? ? Product demo of ECG-AI? LEF ? ? Clinical insights on AI-powered ECG interpretation & integration into your clinical workflow Also, ICYMI, ECG-AI? LEF is now also eligible for reimbursement for Medicare patients in outpatient settings. Stay tuned for more details—we can’t wait to see you at #ACC25! #Cardiology #ECGAI #HeartHealth #ACC25 #AIinMedicine?

    • 该图片无替代文字
  • 查看Anumana的组织主页

    21,006 位关注者

    ?? 20K strong and growing – thank you for being a part of our community!? ? #TeamAnumana is thrilled to celebrate a major milestone: 20,000 followers on LinkedIn! Your support inspires us to keep driving innovation and advancing #AI to unlock the language of the heart. From sharing insights into our work to connecting with this incredible community, we’re grateful for each of you. Here’s to continuing this journey together and making an even greater impact on healthcare. Thank you for being part of the Anumana story! ?????

    • 该图片无替代文字
  • 查看Anumana的组织主页

    21,006 位关注者

    ?? It’s #HeartMonth! ??? ? This February, let’s make a promise to prioritize heart health—for ourselves and those around us. Small, consistent actions can lead to lifelong benefits. ??? ? Start with the #Essential8 from the American Heart Association for a healthier heart. Learn more in the image slides below ????? ? Your heart works tirelessly for you—what will you do for it today? ??? ? Tag a friend or colleague and encourage them to join you in this commitment to better heart health. Let’s make this heart month one to remember!? ? #HeartHealth #Wellness #HeartCare?

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
      +4
  • 查看Anumana的组织主页

    21,006 位关注者

    ?? New Podcast Alert ??? Anumana is focused on delivering evidence-based AI solutions that directly address the real needs of healthcare providers and patients. Our technology is not just about advancing innovation—it’s about building tools that clinicians can trust to make decisions that ultimately improve patient outcomes. As we continue to evolve our ECG-AI solutions, we maintain a strong commitment to data quality, clinical validation, and quality management to ensure our tools can seamlessly integrate into routine practice. In a recent conversation with the Strategy Gap Podcast from AchieveIt with Jonathan Morgan and Joe Krause, MS, MBA, Anumana’s Chief Business Officer David McMullin discusses the importance of balancing operational priorities with strategic vision.? Want to learn about how #TeamAnumana continues to drive innovation while still prioritizing commercial efforts to bring this solution to the hands of clinicians? Tune in! ???? https://lnkd.in/eNv47pSK??

  • 查看Anumana的组织主页

    21,006 位关注者

    ?? Anumana Featured in "2025 Health IT Predictions" by Healthcare IT Today! We’re proud to share that Maulik Nanavaty, our CEO, is featured alongside other industry leaders in Healthcare IT Today’s "Digital Transformation in Healthcare: 2025 Health IT Predictions"! In his prediction, Maulik highlights how evidence-based AI is poised to become the standard of care in healthcare. With FDA-cleared AI algorithms like Anumana’s ECG-AI? LEF, now eligible for reimbursement under the CMS 2025 Hospital Outpatient Prospective Payment System (OPPS), we’re enabling earlier detection of conditions like heart failure and shaping the future clinical intervention and patient care. At Anumana we are committed to our mission of transforming healthcare through innovative AI technologies that address unmet clinical needs while delivering cost-effective solutions. Together, let’s continue redefining what’s possible in healthcare together!? Read the full article here: https://lnkd.in/e4emJivf #DigitalTransformation #HealthTech #AIinHealthcare #2025Predictions #AnumanaAI

  • 查看Anumana的组织主页

    21,006 位关注者

    ??#NEWS??Research published in Mayo Clinic Proceedings Digital Health shows long-term cost-effectiveness of AI enhanced ECG technology for identifying low ejection fraction in outpatient settings. The study builds on real-world data from the EAGLE study, where an early version of Anumana’s ECG-AI LEF was studied.? ??Why does this matter?? Patients with low ejection fraction (weak heart pump) often show no symptoms, making early detection a challenge. Left untreated, this can lead to heart failure, higher medical costs, and poorer outcomes.? With AI enhanced ECG: ? ?? Subtle signals of low ejection fraction are flagged during routine visits? ?? Compared to usual care in outpatient settings, ECG-AI was shown to be a cost-effective addition to patient care?? ? Patients can receive earlier, targeted treatments, delaying or preventing disease progression and lower medical costs over time? As Dr. Peter Noseworthy, MD, cardiologist and co-author of the study, highlights:? Using AI during routine visits can mean earlier treatment for patients, delaying disease progression, and reducing costs over time. ? ?? How do you see AI transforming routine care? Could this be the key to better health outcomes and lower costs in cardiac care?? Learn more: https://lnkd.in/eQtUHgwm #AIinHealthcare #digitalhealth #healthnews #healthinnovation #AIinCardiology??

  • 查看Anumana的组织主页

    21,006 位关注者

    ?? Leadership News! ?? Anumana is thrilled to welcome Dr. Simos Kedikoglou as our new President & Chief Operating Officer (COO)! With a proven track record in healthcare strategy, medical device commercialization, and global leadership, Simos will lead our commercial growth, drive strategic partnerships, and help advance Anuaman’s mission of transforming healthcare with AI-powered solutions. “Simos is a visionary leader with a deep understanding of the healthcare ecosystem and a proven track record of driving growth and innovation in the medtech space,” said Maulik Nanavaty, CEO of Anumana. “We are excited to welcome Simos to our team as we expand our impact in the healthcare industry. His extensive experience in medical device development and commercialization will help Anumana achieve its vision to deliver groundbreaking AI-powered solutions to improve patient outcomes.” We’re excited to have him on board as we continue reshaping patient care through AI. Welcome to the team, Simos! ?? Read the full press release here: https://lnkd.in/ewp_ABtu #Leadership #AIinHealthcare #HealthTech #Innovation #AnumanaAI

    • 该图片无替代文字
  • 查看Anumana的组织主页

    21,006 位关注者

    ?? NEWS ?? We’re proud to share that Anumana is collaborating with AliveCor to develop our advanced AI algorithms for early heart disease detection on AliveCor’s #Kardia ECG devices! ?? ?? Why this matters for clinicians and patients: This collaboration has the potential to leverage Anumana’s industry-leading ECG-AI? algorithms on AliveCor’s Kardia ECG devices to help identify cardiac conditions earlier in the patient’s journey and get them into clinical care sooner. Together, Anumana and AliveCor are reshaping the future of cardiac care. #MedTech #AIinHealthcare #Cardiology Read more: https://lnkd.in/ecYttQM6

    • 该图片无替代文字
  • 查看Anumana的组织主页

    21,006 位关注者

    #TeamAnumana wishes you a very happy and healthy start to the New Year! ?? As we step into 2025, we’re reflecting on an incredible 2024 at #TeamAnumana.? ? #ICYMI, here are some of our key wins: Awards –?? ?? ?Listed by Fast Company in 2024's #NextBigThings in Tech ?? honored with the 2024 MedTech Breakthrough Award for “Best New Technology Solution-Cardiology”? ? Collaborations –?? ?? collaborating with the Accelerating Medicines Partnership Heart Failure Program Foundation for the National Institutes of Health ?? joined the American College of Cardiology Innovation Program to accelerate heart disease detection?? ?? partnering with InfoBionic.Ai to advance AI-powered cardiac telemetry? ? Reimbursement & Quality Milestones –?? ?? Centers for Medicare & Medicaid Services has included ECG-AI technology in the 2025 Hospital Outpatient Prospective Payment System (OPPS) final rule under assignment APC 5734? ?? achieved ISO 13485 Certification, demonstrating global readiness Science & Community –?? ?? conducted groundbreaking research showing the promise of ECG-AI? ?? engaged with the global community across cardiology, internal medicine, and primary care across 10+ conferences? ? We’re excited to continue this journey of innovation and collaboration in 2025. Here’s to even more breakthroughs and successes ahead! ??? ? Want to learn more about Anumana? Get in touch with our team via our website www.anumana.ai?? ? ?#AIinHealthcare #Cardiology #Innovation #MedTech

    • 该图片无替代文字

相似主页

查看职位

融资

Anumana 共 4 轮

上一轮

未知

US$32,000,000.00

Crunchbase 上查看更多信息